This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Virginia Commonwealth University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Rahaman Navaz Gangji
Introduction
Rahaman Navaz Gangji is a notable inventor based in Richmond, VA (US). He has made significant strides in the field of anti-cancer research. His work focuses on developing novel compounds that target cancer stem cells, which are often resistant to conventional therapies.
Latest Patents
Gangji holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These compounds demonstrate promising in vivo anti-cancer activity through selective inhibition of cancer stem cells, while sparing adult or hematopoietic stem cells. The agents exhibit high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. He has 1 patent to his name.
Career Highlights
Gangji is affiliated with Virginia Commonwealth University, where he contributes to cutting-edge research in cancer treatment. His work is pivotal in advancing the understanding of how to effectively target cancer stem cells, which is crucial for improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues such as Umesh R Desai and Balaji Nagarajan. Their combined expertise enhances the research efforts and fosters innovation in the field.
Conclusion
Rahaman Navaz Gangji's contributions to anti-cancer research through his innovative patent highlight his commitment to improving cancer therapies. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile